Key result
NOAC adherence remains essential for clinical benefit in NVAF and requires multi-level educational support.
Population
Patients with non-valvular atrial fibrillation (NVAF)
Design
Review
Authors
Loading...
May warrant enhanced education to improve NOAC adherence in NVAF; leaves open optimal multi-level strategies pending prospective trials.
Adherence to NOACs is critical for clinical benefit in NVAF, requiring multi-level strategies and educational programs to improve patient compliance.
Raparelli et al. (2016) conducted a review in Non-valvular atrial fibrillation (NVAF). Oral anticoagulants (NOACs) vs. Vitamin K antagonists (VKAs) was evaluated. Adherence to non-vitamin K antagonist oral anticoagulants is paramount to achieve clinical benefit in non-valvular atrial fibrillation, requiring multi-level educational and support strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: